Aurora Cannabis generates its operating revenues primarily through the cultivation, processing, and global distribution of medical cannabis products, consumer adult-use recreational cannabis, and plant propagation materials. The enterprise captures significant revenue streams by supplying pharmaceutical-grade medical cannabis to international markets across Europe—particularly Germany—alongside domestic Canadian retail channels, medical clinics, and specialized wellness product divisions.